Clinical Trials · NCT04885634
Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- Axel Brandes
- Enrollment
- 0
- Start date
- Oct 2022
- Locations
- See registry
- Primary endpoint
- Number of Participants to Complete Recruitment